Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.
Young RJ, Solomon B, Corry J, Angel C, Kenny L, Porceddu S, Wratten C, Macann A, Jackson JE, Herschtal A, Rischin D. Young RJ, et al. Among authors: jackson je. Oral Oncol. 2020 Nov;110:104988. doi: 10.1016/j.oraloncology.2020.104988. Epub 2020 Sep 1. Oral Oncol. 2020. PMID: 32889172
Radiotherapy for early non-melanoma skin cancer.
Chua B, Jackson JE, Lin C, Veness MJ. Chua B, et al. Among authors: jackson je. Oral Oncol. 2019 Nov;98:96-101. doi: 10.1016/j.oraloncology.2019.09.018. Epub 2019 Sep 28. Oral Oncol. 2019. PMID: 31574416 Review.
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
Rischin D, King M, Kenny L, Porceddu S, Wratten C, Macann A, Jackson JE, Bressel M, Herschtal A, Fisher R, Fua T, Lin C, Liu C, Hughes BGM, McGrath M, McDowell L, Corry J. Rischin D, et al. Among authors: jackson je. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):876-886. doi: 10.1016/j.ijrobp.2021.04.015. Epub 2021 Jun 4. Int J Radiat Oncol Biol Phys. 2021. PMID: 34098030 Clinical Trial.
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Sultanem K, Richardson K, Mlynarek A, Johnson-Obaseki S, Odell M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Krishnan S, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Wehrli B, Kwan K, Theurer J, Sathya J, Hammond JA, Read N, Venkatesan V, MacNeil SD, Fung K, Nichols AC. Palma DA, et al. Among authors: jackson je. JAMA Oncol. 2022 Jun 1;8(6):1-7. doi: 10.1001/jamaoncol.2022.0615. JAMA Oncol. 2022. PMID: 35482348 Free PMC article. Clinical Trial.
Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy-A Substudy From TROG 12.01.
McDowell L, Rischin D, King M, Kenny L, Porceddu S, Wratten C, Macann A, Jackson JE, Bressel M, Fua T, Lin C, Liu C, Corry J. McDowell L, et al. Among authors: jackson je. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):174-188. doi: 10.1016/j.ijrobp.2022.08.006. Epub 2022 Aug 10. Int J Radiat Oncol Biol Phys. 2023. PMID: 35961477
Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
McDowell L, Bressel M, King MT, Corry J, Kenny L, Porceddu S, Wratten C, Macann A, Jackson JE, Rischin D. McDowell L, et al. Among authors: jackson je. Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1110-1125. doi: 10.1016/j.ijrobp.2023.02.041. Epub 2023 Mar 1. Int J Radiat Oncol Biol Phys. 2023. PMID: 36868523 Clinical Trial.
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.
Ladwa R, Chandra J, Woo WP, Finlayson N, Liu H, McGrath M, See A, Hughes BG, Cooper CL, Jackson JE, Dzienis M, Xu Y, Panizza B, Frazer I, Porceddu SV. Ladwa R, et al. Among authors: jackson je. Front Oncol. 2024 Jul 5;14:1419258. doi: 10.3389/fonc.2024.1419258. eCollection 2024. Front Oncol. 2024. PMID: 39035738 Free PMC article.
364 results